<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03640364</url>
  </required_header>
  <id_info>
    <org_study_id>HCR051631</org_study_id>
    <nct_id>NCT03640364</nct_id>
  </id_info>
  <brief_title>Bilateral Sacrospinous Colposuspension (BSC) in the Female Genital Prolapse With Urinary Urge Symptomatology</brief_title>
  <official_title>Multicenter Prospective Non-randomised Trial of Bilateral Sacrospinous Colposuspension (BSC) in the Treatment of Female Genital Prolapse Accompanied by Urinary Urge Symptomatology</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Helios Medical Center Schleswig</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Helios Medical Center Schleswig</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Prospective non-randomised trial investigating the effect of vaginal vault Suspension on urge&#xD;
      symptomatology in female patients with pelvic organ prolapse&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      A multicenter multinational Trial is performed in 250 female patients with pelvic organ&#xD;
      prolapse (POP) and symptoms of urinary urge incontinence.&#xD;
&#xD;
      Dependent on the presence or abscence of the uterus patients are treated with bilateral&#xD;
      sacrospinous uterine or vaginal vault suspension (BSC) by means of a tape specifically&#xD;
      designed for this purpose.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date type="Actual">April 1, 2018</start_date>
  <completion_date type="Anticipated">June 2021</completion_date>
  <primary_completion_date type="Anticipated">June 2020</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Only</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Influence of BSC placement on symptoms of urinary urge expressed by change in clinical examination</measure>
    <time_frame>Checked after 6 weeks, six months and twelve months</time_frame>
    <description>The change in symptoms after the surgical intervention is evaluated by clinical examination . The clinical examination is descriptive, not quantitative and no units are applicable or reportable.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Change in score of standardized ICIQ documentation</measure>
    <time_frame>Checked after 6 weeks, six months and twelve months</time_frame>
    <description>The International Consultation on Incontinence Questionnaire is used to evaluate Change in Quality of life and urge symptomatology</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Anatomical correction of female pelvic organ prolapse</measure>
    <time_frame>Checked after 6 weeks, six months and twelve months</time_frame>
    <description>Clinical examination of pelvic floor anatomy</description>
  </secondary_outcome>
  <enrollment type="Anticipated">250</enrollment>
  <condition>Urinary Urge Incontinence</condition>
  <eligibility>
    <study_pop>
      <textblock>
        female patients with pelvic organ prolapse suffering from symptoms of urinary urge&#xD;
        incontinence&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  urge urinary incontinence or symptoms thereof&#xD;
&#xD;
          -  18 years old or older&#xD;
&#xD;
          -  Compliance regarding data collection, therapy and follow-up&#xD;
&#xD;
          -  written informed consent&#xD;
&#xD;
          -  simultaneous performance of surgical colporrhaphy permitted&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  pelvic organ prolapse without symptoms of urinary urge&#xD;
&#xD;
          -  age less than 18 years&#xD;
&#xD;
          -  no informed consent&#xD;
&#xD;
          -  lack of compliance&#xD;
&#xD;
          -  adverse reaction to polypropylene&#xD;
&#xD;
          -  life expectancy less than anticipated duration of protocol&#xD;
&#xD;
          -  ASA 4&#xD;
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Dirk G Kieback, MD,Ph.D</last_name>
    <role>Principal Investigator</role>
    <affiliation>Helios Medical Center Schleswig</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Dirk G Kieback, MD, Ph.D</last_name>
    <phone>+49 4621 812</phone>
    <phone_ext>1271</phone_ext>
    <email>dirk.kieback@helios-gesundheit.de</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Marek Volkmer, MD</last_name>
    <phone>+49 4621 812</phone>
    <phone_ext>1271</phone_ext>
    <email>marek.volkmer@helios-gesundheit.de</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Helios Medical Center</name>
      <address>
        <city>Schleswig</city>
        <zip>24837</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Marek Volkmer, MD</last_name>
      <phone>+49 4621 812</phone>
      <phone_ext>1271</phone_ext>
      <email>marek.volkmer@helios-gesundheit.de</email>
    </contact>
    <contact_backup>
      <last_name>Mona Litz</last_name>
      <phone>+49 4621 812</phone>
      <phone_ext>1271</phone_ext>
      <email>mona.litz@elios-gesundheit.de</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <verification_date>August 2018</verification_date>
  <study_first_submitted>August 6, 2018</study_first_submitted>
  <study_first_submitted_qc>August 17, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">August 21, 2018</study_first_posted>
  <last_update_submitted>August 17, 2018</last_update_submitted>
  <last_update_submitted_qc>August 17, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">August 21, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Helios Medical Center Schleswig</investigator_affiliation>
    <investigator_full_name>Dirk G. Kieback, M.D., Ph.D</investigator_full_name>
    <investigator_title>Head, Dept. of Obstetrics and Gynecology</investigator_title>
  </responsible_party>
  <keyword>pelvic organ prolapse</keyword>
  <keyword>incontinence</keyword>
  <keyword>minimally invasive</keyword>
  <keyword>vaginal surgery</keyword>
  <keyword>macroporous</keyword>
  <keyword>lightweight</keyword>
  <keyword>mesh</keyword>
  <keyword>polypropylene</keyword>
  <keyword>POP</keyword>
  <keyword>urge</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Urinary Incontinence, Urge</mesh_term>
    <mesh_term>Prolapse</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

